Alkermes logo

Director, Clinical Operations

Alkermes

Waltham, MAHybridPosted 52 days ago$219,000 - $235,000/year
Full TimeDirector & AboveClinical DevelopmentPharmaceutical
Original posting ↗

Summary

The Director of Clinical Operations in the Discovery Medicine and Pharmaceutical Sciences plays a central role in the execution of Phase 1 clinical studies conducted in healthy volunteers at Alkermes. This role provides operational leadership for healthy volunteer studies across the clinical development lifecycle, ensuring studies are conducted in compliance with GCP, FDA regulations, ICH guidelines, company SOPs, and project timelines.

Job description

The Director will partner closely with Clinical Pharmacology, Translational Medicine, Medical, Biometrics, Regulatory Affairs, Clinical Supply, Quality Assurance, Pharmacovigilance, and CRO partners to ensure successful execution of first-in-human (FIH), SAD, MAD, food effect, relative bioavailability, DDI, QTc, and other early development studies in healthy volunteers.

The successful candidate will be responsible for study budgets, forecasting, resource planning, operational strategy, inspection readiness, eTMF oversight, vendor management, and continuous process improvement and proactive risk identification to ensure on-time delivery of quality trials that meet the highest level of compliance.

Responsibilities

  • Lead planning, execution, and delivery of Phase 1 clinical studies, including FIH, SAD/MAD, food effect, BA/BE, HAP, TQT, DDI, and other studies in healthy volunteers.
  • Develop and manage study timelines, budgets, forecasts, and resource plans to ensure on-time and on-budget delivery.
  • Provide operational input into protocol development, study design, feasibility assessments, and risk mitigation strategies.
  • Oversee CROs, Phase 1 units, laboratories, and clinical vendors, ensuring quality, performance, and adherence to study objectives.
  • Ensure compliance with FDA regulations, ICH-GCP guidelines, company SOPs, and applicable global regulatory requirements.
  • Partner with Clinical Pharmacology, Translational Medicine, Regulatory Affairs, Biostatistics, Medical, Safety, and Clinical Supply teams to support study execution and development objectives.
  • Maintain inspection readiness and oversee eTMF quality, completeness, and timely document filing throughout the study lifecycle.
  • Monitor study progress, enrollment, safety, data quality, and operational metrics, proactively addressing risks and issues.
  • Support IND submissions, protocol amendments, regulatory inspections, audit readiness, study closeout, and CSR activities.
  • Participate in SOP development, process mapping, and other departmental activities.
  • Lead, mentor, and develop Clinical Operations staff while driving operational excellence, process improvements, and a culture of quality and accountability.

Qualifications

Basic Qualifications:

  • B.S, M.S or Ph.D in basic sciences with 12+ years of Clinical Operations experience at biotechnology or pharmaceutical company or CRO
  • Minimum of 5 yrs managing Phase 1 Studies in healthy volunteers

Preferred Qualifications:

  • Prior people management experience preferred.
  • Expertise in Subject Matter and competent in application of standard business procedures (SOPs, ICH, Global Regulations, Ethics and Compliance)

Requirements

  • B.S, M.S or Ph.D in basic sciences
  • 12+ years of Clinical Operations experience at biotechnology or pharmaceutical company or CRO
  • Minimum of 5 yrs managing Phase 1 Studies in healthy volunteers
  • Prior people management experience preferred
  • Expertise in Subject Matter and competent in application of standard business procedures (SOPs, ICH, Global Regulations, Ethics and Compliance)

Benefits

  • Performance pay bonus
  • Competitive benefits package

Company overview

Alkermes plc is a global biopharmaceutical company specializing in neuroscience-focused medicines for psychiatric and neurological disorders. Founded in 1987 and headquartered in Dublin, Ireland, the company maintains a significant research and development center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Alkermes has established itself as a leader in developing treatments for complex conditions including schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. The company's portfolio includes proprietary commercial products such as Lybalvi (olanzapine/samidorphan), Aristada (aripiprazole lauroxil), and Vivitrol (naltrexone), alongside a robust pipeline of clinical and preclinical candidates targeting neurological disorders like narcolepsy and idiopathic hypersomnia. With approximately 1,800-2,100 employees worldwide, Alkermes combines deep neuroscience expertise with sophisticated development capabilities to address traditionally overlooked or stigmatized conditions, maintaining a patient-centered approach to drug development and commercialization.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.